Druggio Logo

Druggio

Janssen Pharmaceutical

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a pharmaceutical company founded in 1953. The company focuses on the research and development of innovative drugs and treatments for a wide range of diseases, including cancer, mental health disorders, infectious diseases, and autoimmune disorders. Some of their notable drugs include Remicade, Invokana, and Xarelto, which are used in the treatment of autoimmune disorders, diabetes, and cardiovascular conditions, respectively. Janssen Pharmaceuticals is known for its commitment to scientific advancement and improving patient outcomes.

Janssen Pharmaceutical's Drugs

Darzquro

Approval date

2021/3/23

Erleada

Approval date

2019/3/26

Tremfya

Approval date

2018/3/23

Sirturo

Approval date

2018/1/19

Darzalex

Approval date

2017/9/27

Imbruvica

Approval date

2016/3/28

Zytiga

Approval date

2014/7/4

Tapenta

Approval date

2014/3/24

Sovriad

Approval date

2013/9/27

Xeplion

Approval date

2013/9/20

Edurant

Approval date

2012/5/18

Simponi

Approval date

2011/7/1

Stelara

Approval date

2011/1/21

Reminyl

Approval date

2011/1/21

Invega

Approval date

2010/10/27

Intelence

Approval date

2008/12/25

Prezista

Approval date

2007/11/22

Velcade

Approval date

2006/10/20

Ultiva

Approval date

2006/10/20

Leustatin

Approval date

2002/1/17

Livostin

Approval date

2000/9/22